Form 8-K - Current report:
SEC Accession No. 0001104659-25-057638
Filing Date
2025-06-09
Accepted
2025-06-09 08:57:15
Documents
13
Period of Report
2025-06-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517477d1_8k.htm   iXBRL 8-K 48861
2 EXHIBIT 99.1 tm2517477d1_ex99-1.htm EX-99.1 41711
  Complete submission text file 0001104659-25-057638.txt   275944

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnk-20250609.xsd EX-101.SCH 3023
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnk-20250609_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnk-20250609_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2517477d1_8k_htm.xml XML 3556
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 251032932
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)